2023 Q4 Form 10-K Financial Statement

#000107068024000006 Filed on March 29, 2024

View on sec.gov

Income Statement

Concept 2023 Q4 2023
Revenue $108.3M
YoY Change 59.79%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $167.0K $567.0K
YoY Change 38.02% 14.31%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $60.64M
YoY Change 219.59%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $5.167M $20.99M
YoY Change -12.36% -7.11%
Income Tax $932.0K $4.048M
% Of Pretax Income 18.04% 19.29%
Net Earnings $4.235M $16.94M
YoY Change -9.33% -6.76%
Net Earnings / Revenue 15.64%
Basic Earnings Per Share $2.64
Diluted Earnings Per Share $0.65 $2.63
COMMON SHARES
Basic Shares Outstanding 6.421M
Diluted Shares Outstanding 6.447M

Balance Sheet

Concept 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $261.6M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $9.033M $9.033M
YoY Change 75.91% 75.91%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $0.00
YoY Change -100.0% -100.0%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $2.059B $2.059B
YoY Change 13.1% 13.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $26.75M $26.75M
YoY Change 13.0% 13.0%
Accrued Expenses $5.302M $5.302M
YoY Change 268.71% 268.71%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $32.05M $32.05M
YoY Change 27.64% 27.64%
LONG-TERM LIABILITIES
Long-Term Debt $14.96M $14.96M
YoY Change 0.26% 0.26%
Other Long-Term Liabilities $2.179M $2.179M
YoY Change -37.97% -37.97%
Total Long-Term Liabilities $17.14M $17.14M
YoY Change -7.02% -7.02%
TOTAL LIABILITIES
Total Short-Term Liabilities $32.05M $32.05M
Total Long-Term Liabilities $17.14M $17.14M
Total Liabilities $1.903B $1.903B
YoY Change 13.23% 13.23%
SHAREHOLDERS EQUITY
Retained Earnings $76.52M
YoY Change 25.24%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $9.991M
YoY Change 3.09%
Treasury Stock Shares
Shareholders Equity $155.4M $155.4M
YoY Change
Total Liabilities & Shareholders Equity $2.059B $2.059B
YoY Change 13.1% 13.1%

Cashflow Statement

Concept 2023 Q4 2023
OPERATING ACTIVITIES
Net Income $4.235M $16.94M
YoY Change -9.33% -6.76%
Depreciation, Depletion And Amortization $167.0K $567.0K
YoY Change 38.02% 14.31%
Cash From Operating Activities $7.951M $18.05M
YoY Change 17.17% -54.6%
INVESTING ACTIVITIES
Capital Expenditures $61.00K $661.0K
YoY Change -42.99% -26.96%
Acquisitions
YoY Change
Other Investing Activities -$35.09M -$121.2M
YoY Change -64.31% -65.61%
Cash From Investing Activities -$35.15M -$121.9M
YoY Change -64.29% -65.51%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 59.01M 213.6M
YoY Change 30.08% -28.5%
NET CHANGE
Cash From Operating Activities 7.951M 18.05M
Cash From Investing Activities -35.15M -121.9M
Cash From Financing Activities 59.01M 213.6M
Net Change In Cash 31.81M 109.8M
YoY Change -168.73% -841.75%
FREE CASH FLOW
Cash From Operating Activities $7.951M $18.05M
Capital Expenditures $61.00K $661.0K
Free Cash Flow $7.890M $17.39M
YoY Change 18.13% -55.25%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 cfbk Deferred Tax Assets Loans Fees
DeferredTaxAssetsLoansFees
CY2023Q4 cfbk Deferred Tax Assets Loans Fees
DeferredTaxAssetsLoansFees
CY2023Q4 cfbk Federal Home Loan Bank Advances And Other Debt Maturities Summary Due In Year Two
FederalHomeLoanBankAdvancesAndOtherDebtMaturitiesSummaryDueInYearTwo
CY2021 cfbk Interest Expense Loans And Leases Heldforsale
InterestExpenseLoansAndLeasesHeldforsale
CY2022 cfbk Interest Expense Loans And Leases Heldforsale
InterestExpenseLoansAndLeasesHeldforsale
CY2023 cfbk Interest Expense Loans And Leases Heldforsale
InterestExpenseLoansAndLeasesHeldforsale
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001070680
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Derivative Asset Statement Of Financial Position Extensible Enumeration
DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#OtherAssets
CY2022Q4 us-gaap Derivative Asset Statement Of Financial Position Extensible Enumeration
DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#OtherAssets
CY2023Q4 us-gaap Derivative Asset Statement Of Financial Position Extensible Enumeration
DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#OtherAssets
CY2021 us-gaap Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration
DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2023#NoninterestIncomeOtherOperatingIncome
CY2022 us-gaap Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration
DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2023#NoninterestIncomeOtherOperatingIncome
CY2023 us-gaap Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration
DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2023#NoninterestIncomeOtherOperatingIncome
CY2021Q4 us-gaap Derivative Liability Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#OtherLiabilities
CY2022Q4 us-gaap Derivative Liability Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#OtherLiabilities
CY2023Q4 us-gaap Derivative Liability Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#OtherLiabilities
CY2023Q4 us-gaap Federal Home Loan Bank Advances Maturities Summary Average Interest Rate Of Amounts Due Within One Year Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryAverageInterestRateOfAmountsDueWithinOneYearOfBalanceSheetDate
CY2022Q4 us-gaap Federal Home Loan Bank Advances Maturities Summary Due From Four To Five Years Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueFromFourToFiveYearsOfBalanceSheetDate
CY2023Q4 us-gaap Federal Home Loan Bank Advances Maturities Summary Due Within One Year Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueWithinOneYearOfBalanceSheetDate
CY2022Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
CY2023 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
CY2023Q4 us-gaap Time Deposit Maturities After Year Five
TimeDepositMaturitiesAfterYearFive
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
0-25045
CY2023 dei Entity Registrant Name
EntityRegistrantName
CF BANKSHARES INC.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
34-1877137
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
4960 E. Dublin Granville Road
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite #400
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Columbus
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
OH
CY2023 dei Trading Symbol
TradingSymbol
CFBK
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
43081
CY2023 dei City Area Code
CityAreaCode
614
CY2023 dei Local Phone Number
LocalPhoneNumber
334-7979
CY2023 dei Security12b Title
Security12bTitle
Common Stock, par value $.01 per share
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
98300000
CY2023 dei Auditor Name
AuditorName
FORVIS, LLP
CY2023 dei Auditor Location
AuditorLocation
Indianapolis, Indiana
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
261595000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
151787000
CY2023Q4 cfbk Interest Bearing Deposits In Other Financial Institutions
InterestBearingDepositsInOtherFinancialInstitutions
100000
CY2022Q4 cfbk Interest Bearing Deposits In Other Financial Institutions
InterestBearingDepositsInOtherFinancialInstitutions
100000
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
8092000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
10442000
CY2023Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
5000000
CY2022Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
5000000
CY2023Q4 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group
LoansReceivableHeldForSaleNetNotPartOfDisposalGroup
1849000
CY2022Q4 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group
LoansReceivableHeldForSaleNetNotPartOfDisposalGroup
580000
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
16865000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
16062000
CY2023Q4 us-gaap Notes Receivable Net
NotesReceivableNet
1694133000
CY2022Q4 us-gaap Notes Receivable Net
NotesReceivableNet
1572255000
CY2023Q4 us-gaap Federal Home Loan Bank Stock And Federal Reserve Bank Stock
FederalHomeLoanBankStockAndFederalReserveBankStock
8482000
CY2022Q4 us-gaap Federal Home Loan Bank Stock And Federal Reserve Bank Stock
FederalHomeLoanBankStockAndFederalReserveBankStock
7942000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3812000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3778000
CY2022Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group Other
AssetsHeldForSaleNotPartOfDisposalGroupOther
1930000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5221000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1357000
CY2023Q4 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
26266000
CY2022Q4 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
25641000
CY2023Q4 us-gaap Other Assets
OtherAssets
44065000
CY2022Q4 us-gaap Other Assets
OtherAssets
39362000
CY2023Q4 us-gaap Assets
Assets
2058615000
CY2022Q4 us-gaap Assets
Assets
1820174000
CY2023Q4 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
235916000
CY2022Q4 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
263241000
CY2023Q4 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
1508141000
CY2022Q4 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
1264681000
CY2023Q4 us-gaap Deposits
Deposits
1744057000
CY2022Q4 us-gaap Deposits
Deposits
1527922000
CY2023Q4 us-gaap Federal Home Loan Bank Advances Long Term
FederalHomeLoanBankAdvancesLongTerm
109995000
CY2022Q4 us-gaap Federal Home Loan Bank Advances Long Term
FederalHomeLoanBankAdvancesLongTerm
109461000
CY2023Q4 us-gaap Advance Payments By Borrowers For Taxes And Insurance
AdvancePaymentsByBorrowersForTaxesAndInsurance
2179000
CY2022Q4 us-gaap Advance Payments By Borrowers For Taxes And Insurance
AdvancePaymentsByBorrowersForTaxesAndInsurance
3513000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
5302000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1438000
CY2023Q4 us-gaap Other Liabilities
OtherLiabilities
26747000
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
23670000
CY2023Q4 us-gaap Subordinated Debt
SubordinatedDebt
14961000
CY2022Q4 us-gaap Subordinated Debt
SubordinatedDebt
14922000
CY2023Q4 us-gaap Liabilities
Liabilities
1903241000
CY2022Q4 us-gaap Liabilities
Liabilities
1680926000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
91068000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
89813000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
76517000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
61095000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2290000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2037000
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
381098
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
365165
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
9991000
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
9692000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
155374000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
139248000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2058615000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1820174000
CY2023 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
97383000
CY2022 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
63717000
CY2021 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
51256000
CY2023 us-gaap Interest Income Debt Securities Operating
InterestIncomeDebtSecuritiesOperating
658000
CY2022 us-gaap Interest Income Debt Securities Operating
InterestIncomeDebtSecuritiesOperating
881000
CY2021 us-gaap Interest Income Debt Securities Operating
InterestIncomeDebtSecuritiesOperating
756000
CY2023 us-gaap Dividend Income Operating
DividendIncomeOperating
592000
CY2022 us-gaap Dividend Income Operating
DividendIncomeOperating
348000
CY2021 us-gaap Dividend Income Operating
DividendIncomeOperating
234000
CY2023 us-gaap Interest Income Federal Funds Sold
InterestIncomeFederalFundsSold
9646000
CY2022 us-gaap Interest Income Federal Funds Sold
InterestIncomeFederalFundsSold
2818000
CY2021 us-gaap Interest Income Federal Funds Sold
InterestIncomeFederalFundsSold
102000
CY2023 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
108279000
CY2022 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
67764000
CY2021 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
52348000
CY2021 cfbk Swap Fee Income
SwapFeeIncome
194000
CY2023 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
940000
CY2022 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
451000
CY2023 us-gaap Interest Expense Deposits
InterestExpenseDeposits
56363000
CY2022 us-gaap Interest Expense Deposits
InterestExpenseDeposits
15952000
CY2021 us-gaap Interest Expense Deposits
InterestExpenseDeposits
8014000
CY2023 us-gaap Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term
InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesLongTerm
3107000
CY2022 us-gaap Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term
InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesLongTerm
2040000
CY2021 us-gaap Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term
InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesLongTerm
1398000
CY2023 us-gaap Interest Expense Subordinated Notes And Debentures
InterestExpenseSubordinatedNotesAndDebentures
1169000
CY2022 us-gaap Interest Expense Subordinated Notes And Debentures
InterestExpenseSubordinatedNotesAndDebentures
982000
CY2021 us-gaap Interest Expense Subordinated Notes And Debentures
InterestExpenseSubordinatedNotesAndDebentures
897000
CY2023 us-gaap Interest Expense
InterestExpense
60639000
CY2022 us-gaap Interest Expense
InterestExpense
18974000
CY2021 us-gaap Interest Expense
InterestExpense
10309000
CY2023 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
47640000
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
48790000
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
42039000
CY2023 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
1858000
CY2022 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
787000
CY2021 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-1600000
CY2023 us-gaap Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal
OffBalanceSheetCreditLossLiabilityCreditLossExpenseReversal
459000
CY2023 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
2317000
CY2022 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
787000
CY2021 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
-1600000
CY2023 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
45323000
CY2022 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
48003000
CY2021 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
43639000
CY2023 us-gaap Investment Banking Revenue
InvestmentBankingRevenue
1566000
CY2022 us-gaap Investment Banking Revenue
InvestmentBankingRevenue
1135000
CY2021 us-gaap Investment Banking Revenue
InvestmentBankingRevenue
845000
CY2023 cfbk Gain Loss On Sales Of Residential Mortgage Loans
GainLossOnSalesOfResidentialMortgageLoans
119000
CY2022 cfbk Gain Loss On Sales Of Residential Mortgage Loans
GainLossOnSalesOfResidentialMortgageLoans
656000
CY2021 cfbk Gain Loss On Sales Of Residential Mortgage Loans
GainLossOnSalesOfResidentialMortgageLoans
5916000
CY2023 cfbk Gain Loss On Sales Of Sba Loans Net
GainLossOnSalesOfSbaLoansNet
66000
CY2022 cfbk Gain Loss On Sales Of Sba Loans Net
GainLossOnSalesOfSbaLoansNet
353000
CY2021 cfbk Gain Loss On Sales Of Sba Loans Net
GainLossOnSalesOfSbaLoansNet
1443000
CY2022 cfbk Gain On Redemption Of Life Insurance Policies
GainOnRedemptionOfLifeInsurancePolicies
-173000
CY2021 cfbk Gain On Redemption Of Life Insurance Policies
GainOnRedemptionOfLifeInsurancePolicies
383000
CY2023 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
625000
CY2022 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
598000
CY2021 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
532000
CY2021 cfbk Gain On Sale Of Deposits
GainOnSaleOfDeposits
1893000
CY2023 cfbk Swap Fee Income
SwapFeeIncome
715000
CY2022 cfbk Swap Fee Income
SwapFeeIncome
190000
CY2021 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
434000
CY2023 us-gaap Noninterest Income
NoninterestIncome
4031000
CY2022 us-gaap Noninterest Income
NoninterestIncome
3210000
CY2021 us-gaap Noninterest Income
NoninterestIncome
11640000
CY2023 us-gaap Labor And Related Expense
LaborAndRelatedExpense
14513000
CY2022 us-gaap Labor And Related Expense
LaborAndRelatedExpense
15125000
CY2021 us-gaap Labor And Related Expense
LaborAndRelatedExpense
16948000
CY2023 us-gaap Occupancy Net
OccupancyNet
1694000
CY2022 us-gaap Occupancy Net
OccupancyNet
1253000
CY2021 us-gaap Occupancy Net
OccupancyNet
1120000
CY2023 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
2172000
CY2022 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
2807000
CY2021 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
2086000
CY2023 us-gaap Taxes Other
TaxesOther
1263000
CY2022 us-gaap Taxes Other
TaxesOther
1151000
CY2021 us-gaap Taxes Other
TaxesOther
975000
CY2023 us-gaap Professional Fees
ProfessionalFees
2470000
CY2022 us-gaap Professional Fees
ProfessionalFees
2758000
CY2021 us-gaap Professional Fees
ProfessionalFees
4348000
CY2023 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
658000
CY2022 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
632000
CY2021 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
622000
CY2023 us-gaap Supplies And Postage Expense
SuppliesAndPostageExpense
149000
CY2022 us-gaap Supplies And Postage Expense
SuppliesAndPostageExpense
183000
CY2021 us-gaap Supplies And Postage Expense
SuppliesAndPostageExpense
146000
CY2023 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
336000
CY2022 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
431000
CY2021 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
3061000
CY2023 us-gaap Communication
Communication
257000
CY2022 us-gaap Communication
Communication
249000
CY2021 us-gaap Communication
Communication
263000
CY2023 us-gaap Loan Portfolio Expense
LoanPortfolioExpense
619000
CY2022 us-gaap Loan Portfolio Expense
LoanPortfolioExpense
694000
CY2021 us-gaap Loan Portfolio Expense
LoanPortfolioExpense
352000
CY2023 us-gaap Depreciation Nonproduction
DepreciationNonproduction
567000
CY2022 us-gaap Depreciation Nonproduction
DepreciationNonproduction
496000
CY2021 us-gaap Depreciation Nonproduction
DepreciationNonproduction
435000
CY2023 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
2215000
CY2022 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
1130000
CY2021 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
1238000
CY2023 cfbk Regulatory Assessment
RegulatoryAssessment
242000
CY2022 cfbk Regulatory Assessment
RegulatoryAssessment
272000
CY2021 cfbk Regulatory Assessment
RegulatoryAssessment
261000
CY2023 cfbk Other Insurance
OtherInsurance
209000
CY2022 cfbk Other Insurance
OtherInsurance
177000
CY2021 cfbk Other Insurance
OtherInsurance
158000
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
60000
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
570000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
17000
CY2023 us-gaap Other Noninterest Expense
OtherNoninterestExpense
945000
CY2022 us-gaap Other Noninterest Expense
OtherNoninterestExpense
693000
CY2021 us-gaap Other Noninterest Expense
OtherNoninterestExpense
431000
CY2023 us-gaap Noninterest Expense
NoninterestExpense
28369000
CY2022 us-gaap Noninterest Expense
NoninterestExpense
28621000
CY2021 us-gaap Noninterest Expense
NoninterestExpense
32461000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
20985000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
22592000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
22818000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4048000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4428000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4365000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
16937000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
18164000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
18453000
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.64
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.84
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.84
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.63
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.78
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.77
CY2023 us-gaap Net Income Loss
NetIncomeLoss
16937000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
18164000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
18453000
CY2023 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-67000
CY2022 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-496000
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-71000
CY2023 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-253000
CY2022 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1867000
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-266000
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-253000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1867000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-266000
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
16684000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
16297000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
18187000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
110210000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
18453000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-266000
CY2021 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
19660
CY2021 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
707000
CY2021 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
185000
CY2021 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
2261
CY2021 cfbk Treasury Stock Value Acquisition Surrendered For Payment Of Taxes
TreasuryStockValueAcquisitionSurrenderedForPaymentOfTaxes
43000
CY2021 cfbk Shares Paid For Tax Withholding For Share Based Compensation Stock Options
SharesPaidForTaxWithholdingForShareBasedCompensationStockOptions
4522
CY2021 cfbk Treasury Stock Value Acquisition Surrendered Exercise Stock Options For Payment Of Taxes And Exercise Proceeds
TreasuryStockValueAcquisitionSurrenderedExerciseStockOptionsForPaymentOfTaxesAndExerciseProceeds
96000
CY2021 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
143551
CY2021 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
2972000
CY2021 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.13
CY2021 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
848000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
125330000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
18164000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1867000
CY2022 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
69648
CY2022 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
899000
CY2022 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
387000
CY2022 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
3424
CY2022 cfbk Treasury Stock Value Acquisition Surrendered For Payment Of Taxes
TreasuryStockValueAcquisitionSurrenderedForPaymentOfTaxes
73000
CY2022 cfbk Shares Paid For Tax Withholding For Share Based Compensation Stock Options
SharesPaidForTaxWithholdingForShareBasedCompensationStockOptions
4366
CY2022 cfbk Treasury Stock Value Acquisition Surrendered Exercise Stock Options For Payment Of Taxes And Exercise Proceeds
TreasuryStockValueAcquisitionSurrenderedExerciseStockOptionsForPaymentOfTaxesAndExerciseProceeds
100000
CY2022 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
110998
CY2022 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
2339000
CY2022 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.18
CY2022 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1153000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
139248000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
16937000
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-253000
CY2023 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
59784
CY2023 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
1172000
CY2023 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
84000
CY2023 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
4875
CY2023 cfbk Treasury Stock Value Acquisition Surrendered For Payment Of Taxes
TreasuryStockValueAcquisitionSurrenderedForPaymentOfTaxes
95000
CY2023 cfbk Shares Paid For Tax Withholding For Share Based Compensation Stock Options
SharesPaidForTaxWithholdingForShareBasedCompensationStockOptions
1555
CY2023 cfbk Treasury Stock Value Acquisition Surrendered Exercise Stock Options For Payment Of Taxes And Exercise Proceeds
TreasuryStockValueAcquisitionSurrenderedExerciseStockOptionsForPaymentOfTaxesAndExerciseProceeds
27000
CY2023 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
9503
CY2023 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
177000
CY2023 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.23
CY2023 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1476000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
155374000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
16937000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
18164000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
18453000
CY2023 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
2317000
CY2022 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
787000
CY2021 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
-1600000
CY2023 us-gaap Depreciation
Depreciation
567000
CY2022 us-gaap Depreciation
Depreciation
496000
CY2021 us-gaap Depreciation
Depreciation
435000
CY2023 us-gaap Adjustment For Amortization
AdjustmentForAmortization
-1024000
CY2022 us-gaap Adjustment For Amortization
AdjustmentForAmortization
-881000
CY2021 us-gaap Adjustment For Amortization
AdjustmentForAmortization
-2505000
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
456000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
215000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
773000
CY2023 us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
10800000
CY2022 us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
97265000
CY2021 us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
2358511000
CY2023 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
9650000
CY2022 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
123655000
CY2021 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
2602993000
CY2023 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
119000
CY2022 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
656000
CY2021 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
5916000
CY2023 cfbk Gain Loss On Sales Of Sba Loans Net
GainLossOnSalesOfSbaLoansNet
66000
CY2022 cfbk Gain Loss On Sales Of Sba Loans Net
GainLossOnSalesOfSbaLoansNet
353000
CY2021 cfbk Gain Loss On Sales Of Sba Loans Net
GainLossOnSalesOfSbaLoansNet
1443000
CY2021 cfbk Gain On Sale Of Deposits
GainOnSaleOfDeposits
1893000
CY2023 us-gaap Asset Impairment Charges
AssetImpairmentCharges
60000
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
570000
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
17000
CY2023 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
-13000
CY2023 us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
625000
CY2022 us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
598000
CY2021 us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
532000
CY2022 cfbk Gain On Redemption Of Life Insurance Policies
GainOnRedemptionOfLifeInsurancePolicies
-173000
CY2021 cfbk Gain On Redemption Of Life Insurance Policies
GainOnRedemptionOfLifeInsurancePolicies
383000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
1172000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
899000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
707000
CY2023 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2676000
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
6475000
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-17880000
CY2023 cfbk Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
687000
CY2022 cfbk Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
568000
CY2021 cfbk Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
461000
CY2023 cfbk Increase Decrease In Operating Lease Right Of Use Liability
IncreaseDecreaseInOperatingLeaseRightOfUseLiability
686000
CY2022 cfbk Increase Decrease In Operating Lease Right Of Use Liability
IncreaseDecreaseInOperatingLeaseRightOfUseLiability
594000
CY2021 cfbk Increase Decrease In Operating Lease Right Of Use Liability
IncreaseDecreaseInOperatingLeaseRightOfUseLiability
498000
CY2023 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
2188000
CY2022 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
1059000
CY2021 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-15135000
CY2022 us-gaap Repayments Of Federal Home Loan Bank Borrowings
RepaymentsOfFederalHomeLoanBankBorrowings
20450000
CY2021 us-gaap Repayments Of Federal Home Loan Bank Borrowings
RepaymentsOfFederalHomeLoanBankBorrowings
228964000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
18051000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
39764000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
253303000
CY2023 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
2013000
CY2022 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
3517000
CY2021 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
5030000
CY2021 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
13070000
CY2021 us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
8000000
CY2023 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
124851000
CY2022 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
364759000
CY2021 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
311232000
CY2022 us-gaap Payments To Acquire Receivables
PaymentsToAcquireReceivables
3698000
CY2021 us-gaap Payments To Acquire Receivables
PaymentsToAcquireReceivables
18677000
CY2023 us-gaap Proceeds From Sale Of Loans Receivable
ProceedsFromSaleOfLoansReceivable
1835000
CY2022 us-gaap Proceeds From Sale Of Loans Receivable
ProceedsFromSaleOfLoansReceivable
12569000
CY2021 us-gaap Proceeds From Sale Of Loans Receivable
ProceedsFromSaleOfLoansReceivable
33361000
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
661000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
905000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2962000
CY2023 cfbk Payments To Acquire Federal Reserve Bank Stock And Federal Home Loan Bank Stock
PaymentsToAcquireFederalReserveBankStockAndFederalHomeLoanBankStock
540000
CY2022 cfbk Payments To Acquire Federal Reserve Bank Stock And Federal Home Loan Bank Stock
PaymentsToAcquireFederalReserveBankStockAndFederalHomeLoanBankStock
627000
CY2021 cfbk Payments To Acquire Federal Reserve Bank Stock And Federal Home Loan Bank Stock
PaymentsToAcquireFederalReserveBankStockAndFederalHomeLoanBankStock
1468000
CY2023 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
1200000
CY2021 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
1500000
CY2023 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
1000000
CY2023 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
659000
CY2022 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
582000
CY2021 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
756000
CY2023 us-gaap Proceeds From Sale Of Other Assets Investing Activities
ProceedsFromSaleOfOtherAssetsInvestingActivities
1892000
CY2021 us-gaap Proceeds From Life Insurance Policies
ProceedsFromLifeInsurancePolicies
661000
CY2021 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
371000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-121853000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-353321000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-316730000
CY2023 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
216135000
CY2022 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
281570000
CY2021 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
237593000
CY2021 cfbk Payment For Assumption Of Deposits In Branch Sale
PaymentForAssumptionOfDepositsInBranchSale
102418000
CY2023 us-gaap Proceeds From Federal Home Loan Bank Borrowings
ProceedsFromFederalHomeLoanBankBorrowings
37075000
CY2022 us-gaap Proceeds From Federal Home Loan Bank Borrowings
ProceedsFromFederalHomeLoanBankBorrowings
40150000
CY2021 us-gaap Proceeds From Federal Home Loan Bank Borrowings
ProceedsFromFederalHomeLoanBankBorrowings
174277000
CY2023 us-gaap Repayments Of Federal Home Loan Bank Borrowings
RepaymentsOfFederalHomeLoanBankBorrowings
36575000
CY2021 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
-70013000
CY2023 us-gaap Increase Decrease In Advance Payments By Borrowers For Taxes And Insurance
IncreaseDecreaseInAdvancePaymentsByBorrowersForTaxesAndInsurance
-1334000
CY2022 us-gaap Increase Decrease In Advance Payments By Borrowers For Taxes And Insurance
IncreaseDecreaseInAdvancePaymentsByBorrowersForTaxesAndInsurance
761000
CY2021 us-gaap Increase Decrease In Advance Payments By Borrowers For Taxes And Insurance
IncreaseDecreaseInAdvancePaymentsByBorrowersForTaxesAndInsurance
1723000
CY2023 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1476000
CY2022 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1153000
CY2021 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
848000
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
84000
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
387000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
185000
CY2023 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
122000
CY2022 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
173000
CY2021 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
139000
CY2023 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
177000
CY2022 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
2339000
CY2021 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
2972000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
213610000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
298753000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8424000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
109808000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-14804000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-55003000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
151787000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
166591000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
221594000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
261595000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
151787000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
166591000
CY2023 us-gaap Interest Paid Net
InterestPaidNet
58799000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
18362000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
10579000
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
3975000
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
2450000
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
3850000
CY2022 us-gaap Transfer Of Loans Held For Sale To Portfolio Loans1
TransferOfLoansHeldForSaleToPortfolioLoans1
1674000
CY2021 us-gaap Transfer Of Loans Held For Sale To Portfolio Loans1
TransferOfLoansHeldForSaleToPortfolioLoans1
16611000
CY2022 cfbk Transfer From Premises And Equipment To Assets Held For Sale
TransferFromPremisesAndEquipmentToAssetsHeldForSale
1930000
CY2023 cfbk Investment Payable On Limited Partnerships
InvestmentPayableOnLimitedPartnerships
889000
CY2022 cfbk Investment Payable On Limited Partnerships
InvestmentPayableOnLimitedPartnerships
8097000
CY2021 cfbk Investment Payable On Limited Partnerships
InvestmentPayableOnLimitedPartnerships
7764000
CY2023 cfbk Noncash Initial Recognition Of Operating Right Of Use Lease Asset
NoncashInitialRecognitionOfOperatingRightOfUseLeaseAsset
4550000
CY2021 cfbk Noncash Initial Recognition Of Operating Right Of Use Lease Asset
NoncashInitialRecognitionOfOperatingRightOfUseLeaseAsset
999000
CY2023 cfbk Noncash Initial Recognition Of Operating Right Of Use Lease Liability
NoncashInitialRecognitionOfOperatingRightOfUseLeaseLiability
4550000
CY2021 cfbk Noncash Initial Recognition Of Operating Right Of Use Lease Liability
NoncashInitialRecognitionOfOperatingRightOfUseLeaseLiability
999000
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Use of Estimates</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">: To prepare financial statements in conformity with U.S. generally accepted accounting principles (GAAP), management makes estimates and assumptions based on available information. These estimates and assumptions affect the amounts reported in the financial statements and the disclosures provided, and actual results could differ. The allowance for credit losses on financial assets, deferred tax assets and fair values of financial instruments are particularly subject to change.</span>
CY2023Q4 cfbk Cash Exceeded Federally Insured Limits Amount
CashExceededFederallyInsuredLimitsAmount
229100000
CY2023Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
225100000
CY2022Q4 cfbk Interest Bearing Deposits In Other Financial Institutions
InterestBearingDepositsInOtherFinancialInstitutions
100000
CY2023Q4 cfbk Interest Bearing Deposits In Other Financial Institutions
InterestBearingDepositsInOtherFinancialInstitutions
100000
CY2023 cfbk Allowance For Credit Losses On Investment Securities Available For Sale Policy Textblock
AllowanceForCreditLossesOnInvestmentSecuritiesAvailableForSalePolicyTextblock
<span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Allowance for credit losses on investment securities available for sale:</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> For investment securities available for sale in an unrealized loss position, the Company first assesses whether it intends to sell, or it is more likely than not that it will be required to sell, the security before recovery of its amortized cost basis. If either of the criteria regarding intent or requirement to sell is met, the security's amortized cost basis is written down to fair value through income. For investment securities available for sale that do not meet the aforementioned criteria, the Company evaluates whether the decline in fair value has resulted from credit losses or other factors. In making this assessment, the Company considers the extent to which fair value is less than amortized cost, any changes to the rating of the security by a rating agency, and adverse conditions specifically related to the security, among other factors. If this assessment indicates that a credit loss exists, the present value of cash flows expected to be collected from the security are compared to the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis, a credit loss exists and an allowance for credit losses is recorded, limited to the amount that the fair value is less than the amortized cost basis. Unrealized losses that have not been recorded through an allowance for credit losses are recognized in other comprehensive income. Adjustments to the allowance for credit losses are reported in the income statement as a component of the provision for credit loss. The Company has made the accounting policy election to exclude accrued interest receivable on investment securities available for sale from the estimate of credit losses. Investment securities available for sale are charged off against the allowance or, in the absence of any allowance, written down through the income statement when deemed uncollectible or when either of the aforementioned criteria regarding intent or requirement to sell is met. The Company did not record an allowance for credit losses on </span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 8pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">its investment securities available for sale as of December 31, 2023, as the unrealized losses were attributable to changes in interest rates, not credit quality.</span></p>
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Concentration of Credit Risk</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">: Most of the Company’s primary business activity is with customers located within the Ohio counties of Franklin, Delaware, Hamilton, Cuyahoga and Summit and Marian County, Indiana and contiguous counties. Therefore, the Company’s exposure to credit risk can be affected by changes in the economies within these counties. Although these counties are the Company’s primary market area for loans, the Company originates residential and commercial real estate loans throughout the United States. </span>
CY2022 us-gaap Investment Tax Credit
InvestmentTaxCredit
2097000
CY2023 us-gaap Investment Tax Credit
InvestmentTaxCredit
2097000
CY2023 us-gaap Gain Loss On Investments
GainLossOnInvestments
2097000
CY2023Q4 us-gaap Other Receivables
OtherReceivables
1909000
CY2022Q4 us-gaap Other Receivables
OtherReceivables
1568000
CY2023 cfbk Joint Venture Incentive Payment
JointVentureIncentivePayment
224000
CY2022 cfbk Joint Venture Incentive Payment
JointVentureIncentivePayment
172000
CY2021 cfbk Joint Venture Incentive Payment
JointVentureIncentivePayment
224000
CY2023 cfbk Percentage Of Recognized Tax Benefits
PercentageOfRecognizedTaxBenefits
0.50
CY2023 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Reclassifications:</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> Some items in the prior year financial statements were reclassified to conform to the current presentation. Reclassifications had no effect on prior period net income or stockholders’ equity.</span>
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
10991000
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
2899000
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
8092000
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
13020000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
2578000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
10442000
CY2022 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Writedown Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesBeforeTax
0
CY2023 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Writedown Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesBeforeTax
0
CY2021 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
0
CY2022 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
0
CY2023 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
0
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
1007000
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
988000
CY2022Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
2001000
CY2022Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
1961000
CY2022Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
1024000
CY2022Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
964000
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
9980000
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
7100000
CY2022Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
9978000
CY2022Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
7500000
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
10991000
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
8092000
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
13020000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
10442000
CY2023 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
778000
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
16865000
CY2023Q4 us-gaap Security Owned And Pledged As Collateral Associated Liabilities Fair Value
SecurityOwnedAndPledgedAsCollateralAssociatedLiabilitiesFairValue
989000
CY2022Q4 us-gaap Security Owned And Pledged As Collateral Associated Liabilities Fair Value
SecurityOwnedAndPledgedAsCollateralAssociatedLiabilitiesFairValue
1446000
CY2021Q4 us-gaap Security Owned And Pledged As Collateral Associated Liabilities Fair Value
SecurityOwnedAndPledgedAsCollateralAssociatedLiabilitiesFairValue
3021000
CY2021Q4 cfbk Number Of Holdings Of Securities Greater Than Ten Percent
NumberOfHoldingsOfSecuritiesGreaterThanTenPercent
0
CY2022Q4 cfbk Number Of Holdings Of Securities Greater Than Ten Percent
NumberOfHoldingsOfSecuritiesGreaterThanTenPercent
0
CY2023Q4 cfbk Number Of Holdings Of Securities Greater Than Ten Percent
NumberOfHoldingsOfSecuritiesGreaterThanTenPercent
0
CY2021Q4 cfbk Minimum Percentage Of Securities Hold
MinimumPercentageOfSecuritiesHold
0.10
CY2022Q4 cfbk Minimum Percentage Of Securities Hold
MinimumPercentageOfSecuritiesHold
0.10
CY2023Q4 cfbk Minimum Percentage Of Securities Hold
MinimumPercentageOfSecuritiesHold
0.10
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
1000
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
8091000
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
2899000
CY2023Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
8092000
CY2023Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
2899000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
1499000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
19000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
8943000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
2559000
CY2022Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
10442000
CY2022Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
2578000
CY2023Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
1710998000
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
1588317000
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
16865000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
16062000
CY2023Q4 us-gaap Notes Receivable Net
NotesReceivableNet
1694133000
CY2022Q4 us-gaap Notes Receivable Net
NotesReceivableNet
1572255000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
16062000
CY2023 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
1858000
CY2023 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
132000
CY2021Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
15508000
CY2022 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
787000
CY2022 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
263000
CY2022 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
30000
CY2022Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
16062000
CY2020Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
17022000
CY2021 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
-1600000
CY2021 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
17000
CY2021 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
103000
CY2021Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
15508000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
16062000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
16062000
CY2022Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
175000
CY2022Q4 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
1588142000
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
1588317000
CY2022 us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
47000
CY2021 us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
169000
CY2021Q4 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
466000
CY2021Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
175000
CY2021 us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
572000
CY2021 us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
23000
CY2021Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
466000
CY2021Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
175000
CY2021 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
572000
CY2021 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
23000
CY2022Q4 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
3242000
CY2022Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
2978000
CY2022Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
20000
CY2022 us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
3030000
CY2022 us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
165000
CY2022Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
3242000
CY2022Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
2978000
CY2022Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
20000
CY2022 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
3030000
CY2022 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
165000
CY2023Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
5722000
CY2023Q4 us-gaap Financing Receivable Nonaccrual No Allowance
FinancingReceivableNonaccrualNoAllowance
2332000
CY2023Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
5700000
CY2022Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
761000
CY2022Q4 cfbk Financing Receivable Nonaccrual And Nonperforming
FinancingReceivableNonaccrualAndNonperforming
761000
CY2022Q4 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
175000
CY2022Q4 cfbk Allocated Specific Reserves To Modified Tdrs
AllocatedSpecificReservesToModifiedTdrs
0
CY2022 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
0
CY2022 us-gaap Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
1
CY2022Q4 cfbk Financing Receivable Recorded Investment Nonaccrual Trouble Debt Restructured
FinancingReceivableRecordedInvestmentNonaccrualTroubleDebtRestructured
80000
CY2023 cfbk Financing Receivable Modified In Period Number Of Loans
FinancingReceivableModifiedInPeriodNumberOfLoans
1
CY2023 us-gaap Financing Receivable Modifications Post Modification Recorded Investment2
FinancingReceivableModificationsPostModificationRecordedInvestment2
2900000
CY2023Q4 us-gaap Financing Receivable Originated In Current Fiscal Year
FinancingReceivableOriginatedInCurrentFiscalYear
217575000
CY2023Q4 us-gaap Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year
FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear
394333000
CY2023Q4 us-gaap Financing Receivable Originated Two Years Before Latest Fiscal Year
FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear
565647000
CY2023Q4 us-gaap Financing Receivable Originated Three Years Before Latest Fiscal Year
FinancingReceivableOriginatedThreeYearsBeforeLatestFiscalYear
137812000
CY2023Q4 us-gaap Financing Receivable Originated Four Years Before Latest Fiscal Year
FinancingReceivableOriginatedFourYearsBeforeLatestFiscalYear
68814000
CY2023Q4 us-gaap Financing Receivable Originated Five Or More Years Before Latest Fiscal Year
FinancingReceivableOriginatedFiveOrMoreYearsBeforeLatestFiscalYear
112677000
CY2023Q4 us-gaap Financing Receivable Revolving
FinancingReceivableRevolving
210582000
CY2023Q4 us-gaap Financing Receivable Revolving Converted To Term Loan
FinancingReceivableRevolvingConvertedToTermLoan
3558000
CY2023Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
1710998000
CY2023 us-gaap Financing Receivable Year Two Originated Fiscal Year Before Current Fiscal Year Writeoff
FinancingReceivableYearTwoOriginatedFiscalYearBeforeCurrentFiscalYearWriteoff
564000
CY2023 us-gaap Financing Receivable Year Three Originated Two Years Before Current Fiscal Year Writeoff
FinancingReceivableYearThreeOriginatedTwoYearsBeforeCurrentFiscalYearWriteoff
211000
CY2023 us-gaap Financing Receivable Originated More Than Five Years Before Current Fiscal Year Writeoff
FinancingReceivableOriginatedMoreThanFiveYearsBeforeCurrentFiscalYearWriteoff
3000
CY2023 cfbk Financing Receivable Allowance For Credit Loss Writeoff
FinancingReceivableAllowanceForCreditLossWriteoff
778000
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
1588317000
CY2023Q4 us-gaap Direct Financing Lease Lease Receivable
DirectFinancingLeaseLeaseReceivable
14343000
CY2022Q4 us-gaap Direct Financing Lease Lease Receivable
DirectFinancingLeaseLeaseReceivable
22533000
CY2023Q4 us-gaap Direct Financing Lease Deferred Selling Profit
DirectFinancingLeaseDeferredSellingProfit
863000
CY2022Q4 us-gaap Direct Financing Lease Deferred Selling Profit
DirectFinancingLeaseDeferredSellingProfit
1798000
CY2023Q4 cfbk Direct Financing Lease Indirect Initial Costs
DirectFinancingLeaseIndirectInitialCosts
17000
CY2022Q4 cfbk Direct Financing Lease Indirect Initial Costs
DirectFinancingLeaseIndirectInitialCosts
33000
CY2023Q4 us-gaap Direct Financing Lease Net Investment In Lease
DirectFinancingLeaseNetInvestmentInLease
13497000
CY2022Q4 us-gaap Direct Financing Lease Net Investment In Lease
DirectFinancingLeaseNetInvestmentInLease
20768000
CY2023Q4 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Next Twelve Months
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths
5917000
CY2023Q4 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Two Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears
5097000
CY2023Q4 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Three Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears
2736000
CY2023Q4 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Four Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears
543000
CY2023Q4 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Five Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFiveYears
50000
CY2023Q4 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived
14343000
CY2022Q4 us-gaap Foreclosed Assets
ForeclosedAssets
0
CY2023Q4 us-gaap Foreclosed Assets
ForeclosedAssets
0
CY2022 cfbk Valuation Allowance On Foreclosed Asset
ValuationAllowanceOnForeclosedAsset
0
CY2023 cfbk Valuation Allowance On Foreclosed Asset
ValuationAllowanceOnForeclosedAsset
0
CY2022 cfbk Foreclosed Assets Net
ForeclosedAssetsNet
0
CY2023 cfbk Foreclosed Assets Net
ForeclosedAssetsNet
0
CY2022Q4 us-gaap Mortgage Loans On Real Estate Commercial And Consumer Net
MortgageLoansOnRealEstateCommercialAndConsumerNet
1163000
CY2023Q4 us-gaap Escrow Deposit
EscrowDeposit
33000
CY2022Q4 us-gaap Escrow Deposit
EscrowDeposit
38000
CY2023Q4 us-gaap Loans Held For Sale Fair Value Disclosure
LoansHeldForSaleFairValueDisclosure
1849000
CY2022Q4 us-gaap Loans Held For Sale Fair Value Disclosure
LoansHeldForSaleFairValueDisclosure
580000
CY2023Q4 cfbk Fair Value Option Loans Held As Assets Contractual Amount
FairValueOptionLoansHeldAsAssetsContractualAmount
1849000
CY2022Q4 cfbk Fair Value Option Loans Held As Assets Contractual Amount
FairValueOptionLoansHeldAsAssetsContractualAmount
580000
CY2023 us-gaap Interest And Fee Income Loans And Leases Held For Sale
InterestAndFeeIncomeLoansAndLeasesHeldForSale
30000
CY2022 us-gaap Interest And Fee Income Loans And Leases Held For Sale
InterestAndFeeIncomeLoansAndLeasesHeldForSale
172000
CY2021 us-gaap Interest And Fee Income Loans And Leases Held For Sale
InterestAndFeeIncomeLoansAndLeasesHeldForSale
5572000
CY2022 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
-356000
CY2021 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
-8408000
CY2023 cfbk Change In Fair Value
ChangeInFairValue
30000
CY2022 cfbk Change In Fair Value
ChangeInFairValue
-184000
CY2021 cfbk Change In Fair Value
ChangeInFairValue
-2836000
CY2023Q4 us-gaap Mortgage Loans On Real Estate Commercial And Consumer Net
MortgageLoansOnRealEstateCommercialAndConsumerNet
991000
CY2023Q4 us-gaap Land And Land Improvements
LandAndLandImprovements
248000
CY2022Q4 us-gaap Land And Land Improvements
LandAndLandImprovements
248000
CY2023Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
2444000
CY2022Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
2295000
CY2023Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
2905000
CY2022Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
3321000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5597000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5864000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1785000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2086000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3812000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3778000
CY2023 us-gaap Depreciation
Depreciation
567000
CY2022 us-gaap Depreciation
Depreciation
496000
CY2021 us-gaap Depreciation
Depreciation
435000
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y10M24D
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0721
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
687000
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
568000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
461000
CY2023 us-gaap Variable Lease Cost
VariableLeaseCost
681000
CY2022 us-gaap Variable Lease Cost
VariableLeaseCost
301000
CY2021 us-gaap Variable Lease Cost
VariableLeaseCost
292000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1034000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
820000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
737000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
687000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
700000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
3407000
CY2023Q4 us-gaap Federal Home Loan Bank Advances Maturities Summary Due After Five Years Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueAfterFiveYearsOfBalanceSheetDate
12500000
CY2022Q4 us-gaap Federal Home Loan Bank Advances Maturities Summary Due After Five Years Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueAfterFiveYearsOfBalanceSheetDate
29500000
CY2023Q4 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
76500000
CY2023Q4 cfbk Advances From Federal Home Loan Banks And Other Debt
AdvancesFromFederalHomeLoanBanksAndOtherDebt
109995000
CY2022Q4 cfbk Advances From Federal Home Loan Banks And Other Debt
AdvancesFromFederalHomeLoanBanksAndOtherDebt
109461000
CY2023Q4 us-gaap Federal Home Loan Bank Advances Maturities Summary Average Interest Rate After Five Years From Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryAverageInterestRateAfterFiveYearsFromBalanceSheetDate
0.0394
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
7385000
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2083000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
5302000
CY2023Q4 us-gaap Time Deposits100000 Or More
TimeDeposits100000OrMore
588849000
CY2022Q4 us-gaap Time Deposits100000 Or More
TimeDeposits100000OrMore
483719000
CY2023Q4 cfbk Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFdicInsuranceLimit
370419000
CY2022Q4 cfbk Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFdicInsuranceLimit
245099000
CY2023Q4 us-gaap Time Deposit Maturities Year One
TimeDepositMaturitiesYearOne
567215000
CY2023Q4 us-gaap Time Deposit Maturities Year Two
TimeDepositMaturitiesYearTwo
60025000
CY2023Q4 us-gaap Time Deposit Maturities Year Three
TimeDepositMaturitiesYearThree
28811000
CY2023Q4 us-gaap Time Deposit Maturities Year Four
TimeDepositMaturitiesYearFour
7401000
CY2023Q4 us-gaap Time Deposits
TimeDeposits
663452000
CY2023Q4 us-gaap Interest Bearing Domestic Deposit Brokered
InterestBearingDomesticDepositBrokered
440350000
CY2022Q4 us-gaap Interest Bearing Domestic Deposit Brokered
InterestBearingDomesticDepositBrokered
291827000
CY2022Q4 us-gaap Federal Home Loan Bank Advances Maturities Summary Due Within One Year Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueWithinOneYearOfBalanceSheetDate
3500000
CY2023Q4 us-gaap Federal Home Loan Bank Advances Maturities Summary Average Interest Rate One To Two Years From Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryAverageInterestRateOneToTwoYearsFromBalanceSheetDate
0.0146
CY2023Q4 us-gaap Federal Home Loan Bank Advances Maturities Summary Due From One To Two Years Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueFromOneToTwoYearsOfBalanceSheetDate
18500000
CY2022Q4 us-gaap Federal Home Loan Bank Advances Maturities Summary Due From One To Two Years Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueFromOneToTwoYearsOfBalanceSheetDate
18500000
CY2023Q4 us-gaap Federal Home Loan Bank Advances Maturities Summary Average Interest Rate Two To Three Years From Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryAverageInterestRateTwoToThreeYearsFromBalanceSheetDate
0.0145
CY2023Q4 us-gaap Federal Home Loan Bank Advances Maturities Summary Due From Two To Three Years Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueFromTwoToThreeYearsOfBalanceSheetDate
16000000
CY2022Q4 us-gaap Federal Home Loan Bank Advances Maturities Summary Due From Two To Three Years Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueFromTwoToThreeYearsOfBalanceSheetDate
16000000
CY2023Q4 us-gaap Federal Home Loan Bank Advances Maturities Summary Average Interest Rate Three To Four Years From Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryAverageInterestRateThreeToFourYearsFromBalanceSheetDate
0.0388
CY2023Q4 us-gaap Federal Home Loan Bank Advances Maturities Summary Due From Three To Four Years Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueFromThreeToFourYearsOfBalanceSheetDate
12500000
CY2022Q4 us-gaap Federal Home Loan Bank Advances Maturities Summary Due From Three To Four Years Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueFromThreeToFourYearsOfBalanceSheetDate
12500000
CY2023Q4 us-gaap Federal Home Loan Bank Advances Maturities Summary Average Interest Rate Four To Five Years From Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryAverageInterestRateFourToFiveYearsFromBalanceSheetDate
0.0169
CY2023Q4 us-gaap Federal Home Loan Bank Advances Maturities Summary Due From Four To Five Years Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueFromFourToFiveYearsOfBalanceSheetDate
17000000
CY2023Q4 us-gaap Federal Home Loan Bank Advances General Debt Obligations Disclosures Collateral Pledged1
FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresCollateralPledged1
393918000
CY2022Q4 us-gaap Federal Home Loan Bank Advances General Debt Obligations Disclosures Collateral Pledged1
FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresCollateralPledged1
356828000
CY2023Q4 us-gaap Federal Home Loan Bank Advances General Debt Obligations Disclosures Maximum Amount Available
FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable
260154000
CY2023Q4 cfbk Federal Home Loan Bank Advances And Other Debt Maturities Summary Due In Next Twelve Months
FederalHomeLoanBankAdvancesAndOtherDebtMaturitiesSummaryDueInNextTwelveMonths
18500000
CY2023Q4 cfbk Federal Home Loan Bank Advances And Other Debt Maturities Summary Due In Year Three
FederalHomeLoanBankAdvancesAndOtherDebtMaturitiesSummaryDueInYearThree
16000000
CY2023Q4 cfbk Federal Home Loan Bank Advances And Other Debt Maturities Summary Due In Year Four
FederalHomeLoanBankAdvancesAndOtherDebtMaturitiesSummaryDueInYearFour
12500000
CY2023Q4 cfbk Federal Home Loan Bank Advances And Other Debt Maturities Summary Due In Year Five
FederalHomeLoanBankAdvancesAndOtherDebtMaturitiesSummaryDueInYearFive
17000000
CY2023Q4 cfbk Federal Home Loan Bank Advances And Other Debt Maturities Summary Total
FederalHomeLoanBankAdvancesAndOtherDebtMaturitiesSummaryTotal
64000000
CY2003Q4 us-gaap Subordinated Debt
SubordinatedDebt
5155000
CY2023Q4 us-gaap Common Stock Held In Trust
CommonStockHeldInTrust
155000
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
3592000
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
4213000
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
3592000
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
456000
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
215000
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
773000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4048000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4428000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4365000
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
4407000
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
4744000
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
4792000
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-7000
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-50000
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-50000
CY2023 cfbk Income Tax Reconciliation Bank Owned Life Insurance Income
IncomeTaxReconciliationBankOwnedLifeInsuranceIncome
131000
CY2022 cfbk Income Tax Reconciliation Bank Owned Life Insurance Income
IncomeTaxReconciliationBankOwnedLifeInsuranceIncome
126000
CY2021 cfbk Income Tax Reconciliation Bank Owned Life Insurance Income
IncomeTaxReconciliationBankOwnedLifeInsuranceIncome
112000
CY2021 cfbk Income Tax Reconciliation Redemption Of Life Insurance Policies
IncomeTaxReconciliationRedemptionOfLifeInsurancePolicies
80000
CY2023 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
194000
CY2022 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
111000
CY2021 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
154000
CY2023 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-27000
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-29000
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-31000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4048000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4428000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4365000
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.19
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.20
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.19
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses
3819000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses
3458000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Postretirement Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits
599000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Postretirement Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits
573000
CY2023Q4 cfbk Deferred Tax Assets Nonaccrual Interest
DeferredTaxAssetsNonaccrualInterest
13000
CY2022Q4 cfbk Deferred Tax Assets Nonaccrual Interest
DeferredTaxAssetsNonaccrualInterest
9000
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
295000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
330000
CY2023Q4 cfbk Deferred Tax Assets Operating Lease Liabilities
DeferredTaxAssetsOperatingLeaseLiabilities
1142000
CY2022Q4 cfbk Deferred Tax Assets Operating Lease Liabilities
DeferredTaxAssetsOperatingLeaseLiabilities
302000
CY2023Q4 us-gaap Deferred Tax Assets Unrealized Losses On Trading Securities
DeferredTaxAssetsUnrealizedLossesOnTradingSecurities
609000
CY2022Q4 us-gaap Deferred Tax Assets Unrealized Losses On Trading Securities
DeferredTaxAssetsUnrealizedLossesOnTradingSecurities
541000
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
6477000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
5213000
CY2023Q4 cfbk Deferred Tax Liabilities Federal Home Loan Bank Stock Dividends
DeferredTaxLiabilitiesFederalHomeLoanBankStockDividends
226000
CY2022Q4 cfbk Deferred Tax Liabilities Federal Home Loan Bank Stock Dividends
DeferredTaxLiabilitiesFederalHomeLoanBankStockDividends
226000
CY2023Q4 cfbk Deferred Tax Liabilities Depreciation
DeferredTaxLiabilitiesDepreciation
469000
CY2022Q4 cfbk Deferred Tax Liabilities Depreciation
DeferredTaxLiabilitiesDepreciation
268000
CY2023Q4 cfbk Deferred Tax Liabilities Operating Lease Right Of Use Assets
DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets
1124000
CY2022Q4 cfbk Deferred Tax Liabilities Operating Lease Right Of Use Assets
DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets
285000
CY2023Q4 us-gaap Deferred Tax Liabilities Deferred Expense Deferred Financing Costs
DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts
9000
CY2022Q4 us-gaap Deferred Tax Liabilities Deferred Expense Deferred Financing Costs
DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts
34000
CY2023Q4 cfbk Deferred Tax Liabilities Limited Partnership Interests
DeferredTaxLiabilitiesLimitedPartnershipInterests
642000
CY2023Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
65000
CY2022Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
70000
CY2023Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
2535000
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
883000
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
3942000
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
4330000
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
3942000
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
4330000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0
CY2012 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
22500000
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
21927000
CY2023 cfbk Operating Loss Carryforwards Limitations On Use Amount
OperatingLossCarryforwardsLimitationsOnUseAmount
163000
CY2023Q4 cfbk Deferred Tax Assets Operating Loss Carryforwards That Will Expire Unutilized Federal
DeferredTaxAssetsOperatingLossCarryforwardsThatWillExpireUnutilizedFederal
20520000
CY2023Q4 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
6977000
CY2023 us-gaap Income Tax Reconciliation Deductions Other
IncomeTaxReconciliationDeductionsOther
2250000
CY2023Q4 us-gaap Deferred Tax Liability Not Recognized Amount Of Unrecognized Deferred Tax Liability Policyholders Surplus
DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus
473000
CY2022Q4 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
8298000
CY2021Q4 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
10137000
CY2023 us-gaap Loans And Leases Receivable Related Parties Additions
LoansAndLeasesReceivableRelatedPartiesAdditions
15604000
CY2022 us-gaap Loans And Leases Receivable Related Parties Additions
LoansAndLeasesReceivableRelatedPartiesAdditions
1189000
CY2023 us-gaap Loans And Leases Receivable Related Parties Proceeds
LoansAndLeasesReceivableRelatedPartiesProceeds
514000
CY2022 us-gaap Loans And Leases Receivable Related Parties Proceeds
LoansAndLeasesReceivableRelatedPartiesProceeds
3028000
CY2023Q4 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
23388000
CY2022Q4 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
8298000
CY2023Q4 us-gaap Related Party Deposit Liabilities
RelatedPartyDepositLiabilities
3922000
CY2022Q4 us-gaap Related Party Deposit Liabilities
RelatedPartyDepositLiabilities
4214000
CY2023 cfbk Number Of Stock Based Compensation Plans
NumberOfStockBasedCompensationPlans
2
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
1172000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
899000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
707000
CY2023 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
246000
CY2022 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
189000
CY2021 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
148000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11089
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.63
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
11089
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.63
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2022Q4 us-gaap Tier One Risk Based Capital
TierOneRiskBasedCapital
176828000
CY2023 cfbk Derivative Loans Sold Notional Amount
DerivativeLoansSoldNotionalAmount
10799000
CY2022 cfbk Derivative Loans Sold Notional Amount
DerivativeLoansSoldNotionalAmount
97265000
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
11089
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
52358
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0
CY2019Q1 cfbk Future Percent Common Equity Of Risk Weighted Assets
FuturePercentCommonEquityOfRiskWeightedAssets
0.025
CY2019Q1 cfbk Common Equity Tier1 Capital To Risk Weighted Assets Ratio
CommonEquityTier1CapitalToRiskWeightedAssetsRatio
0.045
CY2019Q1 cfbk Capital Conservation Buffer
CapitalConservationBuffer
0.025
CY2019Q1 cfbk Common Equity Tier1 Capital To Risk Weighted Assets Upon Full Implementation Ratio
CommonEquityTier1CapitalToRiskWeightedAssetsUponFullImplementationRatio
0.070
CY2019Q1 cfbk Tier1 Capital To Risk Weighted Assets Ratio
Tier1CapitalToRiskWeightedAssetsRatio
0.060
CY2019Q1 cfbk Tier1 Capital To Risk Weighted Assets Upon Full Implementation Ratio
Tier1CapitalToRiskWeightedAssetsUponFullImplementationRatio
0.085
CY2019Q1 cfbk Total Capital To Risk Weighted Assets Ratio
TotalCapitalToRiskWeightedAssetsRatio
0.080
CY2019Q1 cfbk Total Capital To Risk Weighted Assets Upon Full Implementation Ratio
TotalCapitalToRiskWeightedAssetsUponFullImplementationRatio
0.105
CY2019Q1 cfbk Minimum Leverage Ratio Based On Required Basel3 Rules
MinimumLeverageRatioBasedOnRequiredBasel3Rules
0.040
CY2023Q4 us-gaap Capital
Capital
215164000
CY2023Q4 us-gaap Capital To Risk Weighted Assets
CapitalToRiskWeightedAssets
0.1330
CY2023Q4 us-gaap Capital Required To Be Well Capitalized
CapitalRequiredToBeWellCapitalized
161818000
CY2023Q4 us-gaap Capital Required To Be Well Capitalized To Risk Weighted Assets
CapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.1000
CY2023Q4 us-gaap Tier One Risk Based Capital
TierOneRiskBasedCapital
196977000
CY2023Q4 us-gaap Tier One Risk Based Capital To Risk Weighted Assets
TierOneRiskBasedCapitalToRiskWeightedAssets
0.1217
CY2023Q4 us-gaap Tier One Risk Based Capital Required To Be Well Capitalized
TierOneRiskBasedCapitalRequiredToBeWellCapitalized
129455000
CY2023Q4 us-gaap Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets
TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.0800
CY2023Q4 cfbk Common Equity Tier One Risk Based Capital
CommonEquityTierOneRiskBasedCapital
196977000
CY2023Q4 cfbk Common Equity Tier One Risk Based Capital To Risk Weighted Assets
CommonEquityTierOneRiskBasedCapitalToRiskWeightedAssets
0.1217
CY2023Q4 cfbk Common Equity Tier One Risk Based Capital Required To Be Well Capitalized
CommonEquityTierOneRiskBasedCapitalRequiredToBeWellCapitalized
105182000
CY2023Q4 cfbk Common Equity Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets
CommonEquityTierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.0650
CY2023Q4 us-gaap Tier One Leverage Capital
TierOneLeverageCapital
196977000
CY2023Q4 us-gaap Tier One Leverage Capital To Average Assets
TierOneLeverageCapitalToAverageAssets
0.0976
CY2023Q4 us-gaap Tier One Leverage Capital Required To Be Well Capitalized
TierOneLeverageCapitalRequiredToBeWellCapitalized
100908000
CY2023Q4 us-gaap Tier One Leverage Capital Required To Be Well Capitalized To Average Assets
TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets
0.0500
CY2022Q4 us-gaap Capital
Capital
193294000
CY2022Q4 us-gaap Capital To Risk Weighted Assets
CapitalToRiskWeightedAssets
0.1274
CY2022Q4 us-gaap Capital Required To Be Well Capitalized
CapitalRequiredToBeWellCapitalized
151775000
CY2022Q4 us-gaap Capital Required To Be Well Capitalized To Risk Weighted Assets
CapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.1000
CY2022Q4 us-gaap Tier One Risk Based Capital To Risk Weighted Assets
TierOneRiskBasedCapitalToRiskWeightedAssets
0.1165
CY2022Q4 us-gaap Tier One Risk Based Capital Required To Be Well Capitalized
TierOneRiskBasedCapitalRequiredToBeWellCapitalized
121420000
CY2022Q4 us-gaap Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets
TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.0800
CY2022Q4 cfbk Common Equity Tier One Risk Based Capital
CommonEquityTierOneRiskBasedCapital
176828000
CY2022Q4 cfbk Common Equity Tier One Risk Based Capital To Risk Weighted Assets
CommonEquityTierOneRiskBasedCapitalToRiskWeightedAssets
0.1165
CY2022Q4 cfbk Common Equity Tier One Risk Based Capital Required To Be Well Capitalized
CommonEquityTierOneRiskBasedCapitalRequiredToBeWellCapitalized
98654000
CY2022Q4 cfbk Common Equity Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets
CommonEquityTierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.0650
CY2022Q4 us-gaap Tier One Leverage Capital
TierOneLeverageCapital
176828000
CY2022Q4 us-gaap Tier One Leverage Capital To Average Assets
TierOneLeverageCapitalToAverageAssets
0.0989
CY2022Q4 us-gaap Tier One Leverage Capital Required To Be Well Capitalized
TierOneLeverageCapitalRequiredToBeWellCapitalized
89377000
CY2022Q4 us-gaap Tier One Leverage Capital Required To Be Well Capitalized To Average Assets
TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets
0.0500
CY2023Q4 cfbk Opening Balance In Liquidation Account
OpeningBalanceInLiquidationAccount
14300000
CY2023Q4 us-gaap Derivative Assets
DerivativeAssets
4710000
CY2022Q4 us-gaap Derivative Assets
DerivativeAssets
4233000
CY2021Q4 us-gaap Derivative Assets
DerivativeAssets
538000
CY2023Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
4710000
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
4233000
CY2021Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
538000
CY2021 cfbk Derivative Loans Sold Notional Amount
DerivativeLoansSoldNotionalAmount
2358510000
CY2023 us-gaap Gain Loss On Sale Of Mortgage Loans
GainLossOnSaleOfMortgageLoans
119000
CY2022 us-gaap Gain Loss On Sale Of Mortgage Loans
GainLossOnSaleOfMortgageLoans
-64000
CY2021 us-gaap Gain Loss On Sale Of Mortgage Loans
GainLossOnSaleOfMortgageLoans
21646000
CY2022 cfbk Gain Loss On Loans Held For Sale
GainLossOnLoansHeldForSale
-356000
CY2021 cfbk Gain Loss On Loans Held For Sale
GainLossOnLoansHeldForSale
-8408000
CY2022 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1076000
CY2021 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-7322000
CY2023 us-gaap Nonoperating Gains Losses
NonoperatingGainsLosses
119000
CY2022 us-gaap Nonoperating Gains Losses
NonoperatingGainsLosses
656000
CY2021 us-gaap Nonoperating Gains Losses
NonoperatingGainsLosses
5916000
CY2023Q4 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
1300000
CY2023 cfbk Fixed Rate Loan Commitments Expiration Period
FixedRateLoanCommitmentsExpirationPeriod
P60D
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
16937000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
18164000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
18453000
CY2023 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
6547283
CY2022 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
6508064
CY2021 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
6605278
CY2023 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
126195
CY2022 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
111011
CY2021 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
97122
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6421088
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6397053
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6508156
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.64
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.84
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.84
CY2023 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
16937000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
18164000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
18453000
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6421088
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6397053
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6508156
CY2023 cfbk Dilutive Effect Of Employee Stock Options Shares Used In Computation
DilutiveEffectOfEmployeeStockOptionsSharesUsedInComputation
3353
CY2022 cfbk Dilutive Effect Of Employee Stock Options Shares Used In Computation
DilutiveEffectOfEmployeeStockOptionsSharesUsedInComputation
27096
CY2021 cfbk Dilutive Effect Of Employee Stock Options Shares Used In Computation
DilutiveEffectOfEmployeeStockOptionsSharesUsedInComputation
45169
CY2023 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
23006
CY2022 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
111011
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
97122
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6447447
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6535160
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6650447
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.63
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.78
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.77
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Consideration
DisposalGroupIncludingDiscontinuedOperationConsideration
2010000
CY2022Q3 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
542000
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023 dei Auditor Firm
AuditorFirmId
686

Files In Submission

Name View Source Status
0001070680-24-000006-index-headers.html Edgar Link pending
0001070680-24-000006-index.html Edgar Link pending
0001070680-24-000006.txt Edgar Link pending
0001070680-24-000006-xbrl.zip Edgar Link pending
cfbk-20231231.xsd Edgar Link pending
cfbk-20231231x10k.htm Edgar Link pending
cfbk-20231231xex21_1.htm Edgar Link pending
cfbk-20231231xex23_1.htm Edgar Link pending
cfbk-20231231xex31_1.htm Edgar Link pending
cfbk-20231231xex31_2.htm Edgar Link pending
cfbk-20231231xex32_1.htm Edgar Link pending
cfbk-20231231xex4_4.htm Edgar Link pending
cfbk-20231231xex4_5.htm Edgar Link pending
cfbk-20231231xex4_5g001.jpg Edgar Link pending
cfbk-20231231xex97.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R106.htm Edgar Link pending
R107.htm Edgar Link pending
R108.htm Edgar Link pending
R109.htm Edgar Link pending
R11.htm Edgar Link pending
R110.htm Edgar Link pending
R111.htm Edgar Link pending
R112.htm Edgar Link pending
R113.htm Edgar Link pending
R114.htm Edgar Link pending
R115.htm Edgar Link pending
R116.htm Edgar Link pending
R117.htm Edgar Link pending
R118.htm Edgar Link pending
R119.htm Edgar Link pending
R12.htm Edgar Link pending
R120.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
cfbk-20231231_lab.xml Edgar Link unprocessable
cfbk-20231231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cfbk-20231231x10k_htm.xml Edgar Link completed
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
cfbk-20231231_cal.xml Edgar Link unprocessable
cfbk-20231231_def.xml Edgar Link unprocessable